Inventor · disambiguated record
Linda Jolliffe
Also filed as: JOLLIFFE LINDA · JOLLIFFE LINDA K · JOLLIFFE LINDA KAY
15 granted patents·11 pending applications·1,544 citations·filing 1993–2009
95Inventor score
Files withORTHO MCNEIL PHARM INC6SCRIPPS RESEARCH INST4BLUESTONE JEFFREY A2RENZI MICHAEL2AFFYMAX TECH NV1
Top patents by PatentIndex Score
26 records- 0198US5929212ACD3 specific recombinant antibodyCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jul 27, 1999·298 cites·13 claims
- 0297US5773569ACompounds and peptides that bind to the erythropoietin receptorAFFYMAX TECH NV·Filed 1995·Granted Jun 30, 1998·416 cites·8 claims
- 0396US5885573AMethods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesARCH DEV CORP·Filed 1993·Granted Mar 23, 1999·400 cites·3 claims
- 0493US6750325B1CD3 specific recombinant antibodyCELLTECH R&D LTD·Filed 1999·Granted Jun 15, 2004·118 cites·9 claims
- 0593US6491916B1Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodiesTOLERANCE THERAPEUTICS INC·Filed 1994·Granted Dec 10, 2002·152 cites·5 claims
- 0688US5835382ASmall molecule mimetics of erythropoietinSCRIPPS RESEARCH INST·Filed 1996·Granted Nov 10, 1998·64 cites·6 claims
- 0784US6710048B2Pyrazine derivatives as modulators of tyrosine kinasesORTHO MCNEIL PHARM INC·Filed 2001·Granted Mar 23, 2004·25 cites·71 claims
- 0879US7232797B2Erythropoietin dosing regimen for treating anemiaORTHO MCNEIL PHARM INC·Filed 2002·Granted Jun 19, 2007·12 cites·10 claims
- 0973US7259146B2Neuroprotective peptidesORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 21, 2007·3 cites·4 claims
- 1072US6221608B1Methods for identifying erythropoietin receptor binding proteinORTHO PHARMA CORP·Filed 1997·Granted Apr 24, 2001·46 cites·1 claims
- 1169US7129267B2Methods for SHP1 mediated neuroprotectionJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Oct 31, 2006·4 cites·1 claims
- 1266US7272508B2Small molecule mimetics of erythropoietinSCRIPPS RESEARCH INST·Filed 2005·Granted Sep 18, 2007·1 cites·2 claims
- 1366US2010250600A1Small Molecule Mimetics of ErythropoietinSCRIPPS RESEARCH INST·Filed 2009·Application pending·0 cites
- 1463US6890921B1Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasiaORTHO MCNEIL PHARM INC·Filed 2000·Granted May 10, 2005·1 cites·13 claims
- 1563US6593474B1Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasiaORTHO MCNEIL PHARM INC·Filed 2000·Granted Jul 15, 2003·1 cites·3 claims
- 1659US2003108548A1Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesFiled 2002·Application pending·0 cites
- 1755US2009119019A1Small Molecule Mimetics of ErythropoietinSCRIPPS RESEARCH INST·Filed 2007·Application pending·0 cites
- 1854US2009170759A1Neuroprotective peptidesSMITH-SWINTOSKY VIRGINIA·Filed 2007·Application pending·0 cites
- 1954US2007065885A1Methods for shp1 mediated neuroprotectionRENZI MICHAEL·Filed 2006·Application pending·0 cites
- 2053US2006292142A1Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesBLUESTONE JEFFREY A·Filed 2006·Application pending·0 cites
- 2153US2003220493A1Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasiaFiled 2003·Application pending·0 cites
- 2250US2006002933A1Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesBLUESTONE JEFFREY A·Filed 2005·Application pending·0 cites
- 2346US2004209812A1Use of erythropoietin in stroke recoveryFiled 2004·Application pending·0 cites
- 2444US2007009967A1Methods for shp1 mediated neuroprotectionRENZI MICHAEL·Filed 2006·Application pending·0 cites
- 2542US6071915AArylsubstituted piperazines useful in the treatment of benign prostatic hyperplasiaORTHO MCNEIL PHARM INC·Filed 1998·Granted Jun 6, 2000·3 cites·3 claims
- 2630US2002099179A1Cdr-grafted antibodiesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Linda Jolliffe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →